Dong Yang

Dr. Dong Yang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2024 in Pharmacology Research & Perspectives
Verified
Journal Article
Open access
YSYiyi Shou
Yiyi Shou
XLXingyu Li
Xingyu Li
QFQuan Fang
Quan Fang
AXAqiong Xie
Aqiong Xie
YZYinghong Zhang
Yinghong Zhang
DYDong Yang
Dong Yang
Diabetic cardiomyopathy (DCM) is a condition characterized by myocardial dysfunction that occurs in individuals with diabetes, in the absence of coronary artery disease, valve disease, and other conventional cardiovascular risk factors such as hypertension and dyslipidemia. It is considered a significant and consequential complication of diabetes in the field of cardiovascular medicine. The primary pathological manifestations include myocardial hypertrophy, myocardial fibrosis, and impaired ventricular function, which can lead to widespread myocardial necrosis. Ultimately, this can progress to the development of heart failure, arrhythmias, and cardiogenic shock, with severe cases even resulting in sudden cardiac death. Despite several decades of both fundamental and clinical research conducted globally, there are currently no specific targeted therapies available for DCM in clinical practice, and the incidence and mortality rates of heart failure remain persistently high. Thus, this article provides an overview of the current treatment modalities and novel techniques pertaining to DCM, aiming to offer valuable insights and support to researchers dedicated to investigating this complex condition.

10 March 2022 in Journal of Infection
Verified
Journal Article
Closed access
CCChen Chen
Chen Chen
JTJiake Tang
Jiake Tang
CWChunyi Wang
Chunyi Wang
WWWen Wen
Wen Wen
YCYongran Cheng
Yongran Cheng
DYDong Yang
Dong Yang

17 November 2025 in Polymers
Verified
Journal Article
Open access
PDF file
JWJiayao Wang
Jiayao Wang
JZJingxin Zhao
Jingxin Zhao
DYDong Yang
Dong Yang
Jichun YouJichun You
Jichun You
Guipeng YuGuipeng Yu
Guipeng Yu
In this work, an innovative approach has been established to overcome the intrinsic limitations of poly(L-lactic acid) (PLLA)-based shape memory polymers (SMPs) by introducing γ-ray-induced crosslinking in miscible PLLA/triallyl isocyanurate (TAIC) blends. The crosslinking density can be precisely adjusted by the TAlC content and absorbed irradiation dose, enabling the fabrication of PLLA SMPS with outstanding shape memory properties. In crosslinked PLLA SMPs, the crosslinking point can significantly suppress the cold crystallization and prevent the irreversible chain slippage during deformation in the shape memory process, resulting in not only a high shape recovery ratio (99.5% at 10 wt% TAIC) but also a good cycle stability (maintaining 97.9% after three cycles). Moreover, the crosslinking points as well as the PLLA crystals endow PLLA with triple-shape memory performance, in which both the glass transition temperature and melting temperature serve as switch conditions. Remarkably, even under extreme deformation conditions (strain up to 800%), the crosslinked PLLA SMPs maintain a recovery ratio as high as 99.3%. Our results offer a novel strategy for fabricating high-performance PLLA SMPs with exceptional shape recovery capabilities.